Skip to content

Effect Of Tila Shelu Karvi Kwath With Hingu triguna Taila Matra Basti On Scanty Menses

A Clinical Study To Evaluate The Efficacy Of Tila Shelu Karvi Kwath With Hingu Triguna Taila Matra Basti On Artvakshaya w.s.r.To Oligomenorrhea And Hypomenorrhea

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047242
Enrollment
30
Registered
2022-11-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N915- Oligomenorrhea, unspecified

Interventions

None listed

Sponsors

Madan Mohan Malviya Govt. Ayurved College Udaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.patient willing for the trial. 2.patient between the age group of 16-40 years. 3.oligomenorrhea(delayed menses). 4.hypomenorrhea(scanty menses).

Exclusion criteria

Exclusion criteria: 1.patient in before 16 years after 40 years of age. 2.pregant women 3.lactating women. 4. HB level less than 7 gm%.5. patient having sex chromosomal abnormalities, congenital abnormalities( Turner syndrome etc.), patient suffering from chronic systemic disease and malignancy.

Design outcomes

Primary

MeasureTime frame
1)Improvement in signs and symptoms of arthavakshaya 2) Improvement in menstrual pain, duration of menstrual bleeding , amount of menstrual flow and interval between two cycles.Timepoint: 3 months

Secondary

MeasureTime frame
1)Improvement in signs and symptoms of arthavakshaya 2) Improvement in menstrual pain, duration of menstrual bleeding , amount of menstrual flow and interval between two cycles.Timepoint: 15 days,30 days,45 days,60 days and 75 days

Countries

India

Contacts

Public ContactDr Narendra Kumar Meena

Madan Mohan Malviya Govt. Ayurved College Udaipur

narendermeena42@yahoo.com9950129673

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026